Association between elevated coffee consumption and daily chocolate intake with normal liver enzymes in HIV-HCV infected individuals: Results from the ANRS CO13 HEPAVIH cohort study

Journal of Hepatology

Volumn 60, Issue 1, 2014, Pages 46-53

  Carrieri, M Patrizia ^a,b,c   Lions, Caroline ^a,b,c   Sogni, Philippe ^d,e   Winnock, Maria ^f   Roux, Perrine ^a,b,c   Mora, Marion ^a,b,c   Bonnard, Philippe ^g   Salmon, Dominique ^e,h   Dabis, François ^f   Spire, Bruno ^a,b,c  

^a AIX MARSEILLE UNIV   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

^c OBSERVATOIRE RÉGIONAL DE LA SANTÉ PROVENCE ALPES CÔTE D AZUR   (France)

^d INSTITUT COCHIN   (France)

^e Service d'Hépatologie ^*  (France)

^f INSERM   (France)

^g HÔPITAL TENON   (France)

^h UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Chocolate; Cocoa; Coffee; Hepatitis C; HIV; Liver enzyme; Polyphenol

Indexed keywords

ALANINE AMINOTRANSFERASE; AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; LIVER ENZYME; POLYPHENOL; ANTIRETROVIRUS AGENT; NEVIRAPINE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CACAO; COFFEE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOOD INTAKE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFORMATION PROCESSING; LIVER DISEASE; LIVER INJURY; LIVER PROTECTION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PRIORITY JOURNAL; SUPPLEMENTATION; ALCOHOL CONSUMPTION; QUESTIONNAIRE; VIRUS LOAD;

AGENCY FOR RESEARCH ON AIDS AND VIRAL HEPATITIS; ALANINE AMINOTRANSFERASE; ALCOHOL UNITS; ALCOHOL USE DISORDERS IDENTIFICATION TEST; ALT; ANRS; ANTIRETROVIRAL TREATMENT; ART; ASPARTATE AMINOTRANSFERASE; AST; AU; AUDIT-C; BMI; BODY MASS INDEX; CD4; CDC; CENTERS FOR DISEASE CONTROL AND PREVENTION; CHOCOLATE; CLUSTER OF DIFFERENTIATION 4; COCOA; COFFEE; GEE; GENERALIZED ESTIMATING EQUATIONS; HCV; HEPATITIS C; HEPATITIS C VIRUS; HIV; HUMAN IMMUNODEFICIENCY VIRUS; IDU; INTERNATIONAL UNITS/LITER; INTERQUARTILE RANGE; INTRAVENOUS DRUG USERS; IQR; IU/L; KILOPASCAL; KPA; LIVER ENZYME; ODDS RATIO; OR; PEGIFN; PEGYLATED INTERFERON; POLYPHENOL; RIBONUCLEIC ACID; RNA; TGF-BETA; TRANSFORMING GROWTH FACTOR BETA; UNL; UPPER NORMAL LEVEL;

ADULT; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; CACAO; COFFEE; COHORT STUDIES; COINFECTION; FEMALE; HEPATITIS C; HIV INFECTIONS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED;

EID: 84890551705     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2013.08.014     Document Type: Article

References (33)

1. G.L. Armstrong, A. Wasley, E.P. Simard, G.M. McQuillan, W.L. Kuhnert, and M.J. Alter The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 Ann Intern Med 144 2006 705 714
2. C. Trepo, and P. Pradat Hepatitis C virus infection in Western Europe J Hepatol 31 1999 80 83
3. N. Muhlberger, R. Schwarzer, B. Lettmeier, G. Sroczynski, S. Zeuzem, and U. Siebert HCV-related burden of disease in Europe: a systematic assessment of incidence, prevalence, morbidity, and mortality BMC Public Health 9 2009 34
4. M.S. Sulkowski, D.L. Thomas, S.H. Mehta, R.E. Chaisson, and R.D. Moore Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: role of hepatitis C and B infections Hepatology 35 2002 182 189
5. C.E. Ruhl, and J.E. Everhart Coffee and caffeine consumption reduce the risk of elevated serum alanine aminotransferase activity in the United States Gastroenterology 128 2005 24 32
6. A.A. Modi, J.J. Feld, Y. Park, D.E. Kleiner, J.E. Everhart, and T.J. Liang Increased caffeine consumption is associated with reduced hepatic fibrosis Hepatology 51 2010 201 209
7. G. Corrao, A.R. Lepore, P. Torchio, M. Valenti, G. Galatola, and A. D'Amicis The effect of drinking coffee and smoking cigarettes on the risk of cirrhosis associated with alcohol consumption. A case-control study. Provincial Group for the Study of Chronic Liver Disease Eur J Epidemiol 10 1994 657 664
8. F. Bravi, C. Bosetti, A. Tavani, V. Bagnardi, S. Gallus, and E. Negri Coffee drinking and hepatocellular carcinoma risk: a meta-analysis Hepatology 46 2007 430 435
9. C. Selmi, C.A. Cocchi, M. Lanfredini, C.L. Keen, and M.E. Gershwin Chocolate at heart: the anti-inflammatory impact of cocoa flavanols Mol Nutr Food Res 52 2008 1340 1348
10. C.M. Braganca de Moraes, D.A. Melo, R.C. Santos, S. Bitencourt, F.C. Mesquita, and F.D. Santos de Oliveira Antiproliferative effect of catechin in GRX cells Biochem Cell Biol 90 2012 575 584
11. G.C. Di Renzo, E. Brillo, M. Romanelli, G. Porcaro, F. Capanna, and T.T. Kanninen Potential effects of chocolate on human pregnancy: a randomized controlled trial J Matern Fetal Neonatal Med 25 2012 1860 1867
12. M.A. Loko, D. Salmon, P. Carrieri, M. Winnock, M. Mora, and L. Merchadou The French national prospective cohort of patients co-infected with HIV and HCV (ANRS CO13 HEPAVIH): early findings, 2006-2010 BMC Infect Dis 10 2011 303
13. A. Alberti, N. Clumeck, S. Collins, W. Gerlich, J. Lundgren, and G. Palu Short statement of the first European Consensus Conference on the treatment of chronic hepatitis B and C in HIV co-infected patients J Hepatol 42 2005 615 624
14. D. Dhumeaux, P. Marcellin, and E. Lerebours Treatment of hepatitis C. The 2002 french consensus Gut 52 2003 1784 1787
15. N.D. Freedman, J.E. Everhart, K.L. Lindsay, M.G. Ghany, T.M. Curto, and M.L. Shiffman Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C Hepatology 50 2009 1360 1369
16. N. Chalasani, E. Teal, and S.D. Hall Effect of rosiglitazone on serum liver biochemistries in diabetic patients with normal and elevated baseline liver enzymes Am J Gastroenterol 100 2005 1317 1321
17. S.L. Zeger, and K.Y. Liang Longitudinal data analysis for discrete and continuous outcomes Biometrics 42 1986 121 130
18. J.B. Carlin, R. Wolfe, C. Coffey, and G.C. Patton Analysis of binary outcomes in longitudinal studies using weighted estimating equations and discrete-time survival methods: prevalence and incidence of smoking in an adolescent cohort Stat Med 18 1999 2655 2679
19. R. Gonzalez, I. Ballester, R. Lopez-Posadas, M.D. Suarez, A. Zarzuelo, and O. Martinez-Augustin Effects of flavonoids and other polyphenols on inflammation Crit Rev Food Sci Nutr 51 2011 331 362
20. I. Amin, B.K. Koh, and R. Asmah Effect of cacao liquor extract on tumor marker enzymes during chemical hepatocarcinogenesis in rats J Med Food 7 2004 7 12
21. S. Gallus, A. Tavani, E. Negri, and C. La Vecchia Does coffee protect against liver cirrhosis? Ann Epidemiol 12 2002 202 205
22. A. Tverdal, and S. Skurtveit Coffee intake and mortality from liver cirrhosis Ann Epidemiol 13 2003 419 423
23. N.D. Freedman, T.M. Curto, K.L. Lindsay, E.C. Wright, R. Sinha, and J.E. Everhart Coffee consumption is associated with response to peginterferon and ribavirin therapy in patients with chronic hepatitis C Gastroenterology 140 2011 1961 1969
24. M.P. Carrieri, P. Sogni, J. Cohen, M.A. Loko, M. Winnock, and B. Spire Elevated coffee consumption and reduced risk of insulin resistance in HIV-HCV co-infected patients (HEPAVIH ANRS CO-13) Hepatology 56 2012 2010
25. S. Almoosawi, C. Tsang, L.M. Ostertag, L. Fyfe, and E.A. Al-Dujaili Differential effect of polyphenol-rich dark chocolate on biomarkers of glucose metabolism and cardiovascular risk factors in healthy, overweight and obese subjects: a randomized clinical trial Food Funct 3 2012 1035 1043
26. S.J. Hutchinson, S.M. Bird, and D.J. Goldberg Influence of alcohol on the progression of hepatitis C virus infection: a meta-analysis Clin Gastroenterol Hepatol 3 2005 1150 1159
27. K. Koike, T. Tsutsumi, H. Miyoshi, S. Shinzawa, Y. Shintani, and H. Fujie Molecular basis for the synergy between alcohol and hepatitis C virus in hepatocarcinogenesis J Gastroenterol Hepatol 23 2008 S87 S91
28. Y. Benhamou, V. Di Martino, M. Bochet, G. Colombet, V. Thibault, and A. Liou Factors affecting liver fibrosis in human immunodeficiency virus-and hepatitis C virus-coinfected patients: impact of protease inhibitor therapy Hepatology 34 2001 283 287
29. M. Grignon, M. Perronnin, and J.N. Lavis Does free complementary health insurance help the poor to access health care? Evidence from France Health Econ 17 2008 203 219
30. P. Roux, J. Cohen, C. Lascoux-Combe, P. Sogni, M. Winnock, and D. Salmon-Ceron Determinants of the underreporting of alcohol consumption by HIV/HCV co-infected patients during face-to-face medical interviews: the role of the physician Drug Alcohol Depend 116 2011 228 232
31. M. Hesselbrock, T.F. Babor, V. Hesselbrock, R.E. Meyer, and K. Workman "Never believe an alcoholic"? On the validity of self-report measures of alcohol dependence and related constructs Int J Addict 18 1983 593 609
32. S. Ciesek, T. von Hahn, C.C. Colpitts, L.M. Schang, M. Friesland, and J. Steinmann The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entry Hepatology 54 2011 1947 1955
33. Y. Li, S.C. Chang, B.Y. Goldstein, W.L. Scheider, L. Cai, and N.C. You Green tea consumption, inflammation and the risk of primary hepatocellular carcinoma in a Chinese population Cancer Epidemiol 35 2011 362 368